课题基金 / 基金详情

Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy

Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
学术-工业合作伙伴关系将 4D 体内剂量测定方法转化为放射治疗
批准号:
10260605
负责人:
Yong Chen
金额:
$39.28万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-20 至 2024-08-31

项目摘要

项目成果

Yong Chen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Overall Objective of this application is to enable in vivo dosimetry during radiation therapy in cancer patient to the end-user– the medical physicist. Our Hypothesis is that X-ray-induced Acoustic Computed tomography (XACT) can be used for 4D in vivo dosimetry in patients. In XACT, pulsed x-rays are absorbed and converted to heat. The resulting thermoelastic expansion generates a 3D acoustic wave, which can be detected by acoustic detectors to form images. The amplitude of the acoustic waves is proportional to X-ray absorption, and therefore encodes dose information. Our overall strategy is to design/construct a 3D XACT dosimetric scanner, and to test/refine the imaging prototype under clinical conditions based on an Academic-Industrial partnership between University of Oklahoma (OU) and PhotoSound Technologies Inc. Our specific aims are: (Specific aim 1) Evaluate the basis of the XACT imaging in radiotherapy dosimetry; (Specific aim 2) Develop a 3D XACT imaging system for clinical implementation; and (Specific aim 3) Validate the performance of XACT under clinical conditions. This discovery is the first time in history that radiation dose in tissue could be directly visualized with high spatial and temporal resolution. If successful, the ability to localize the radiation beam and map the radiation dose will enable a paradigm shift towards high-precision radiotherapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity
  • 批准号:
    10740289
  • 项目类别:
  • 资助金额:
    $48.21万
  • 财政年份:
    2023
  • 负责人:
    Yong Chen
  • 依托单位:
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
  • 批准号:
    10713097
  • 项目类别:
  • 资助金额:
    $56.39万
  • 财政年份:
    2023
  • 负责人:
    Yong Chen
  • 依托单位:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
  • 批准号:
    10522570
  • 项目类别:
  • 资助金额:
    $46.47万
  • 财政年份:
    2022
  • 负责人:
    Yong Chen
  • 依托单位:
海外基金